Europe, China clamp down in face of surging COVID-19 infections

Countries across the globe are struggling to contain surging coronavirus infections driven by the Omicron variant.

Countries across the globe are struggling to contain surging coronavirus infections driven by the Omicron variant, especially in its epicentre Europe.

The Omicron variant of the coronavirus is spreading quickly across the world. Source: Press Association

European nations reimposed tough rules and China locked down millions on Thursday, as countries scrambled to contain surging coronavirus infections driven by the Omicron variant.

The United Kingdom said the risk of hospitalisation was as much as 70 per cent lower among people infected with Omicron compared to the previously dominant Delta strain, echoing studies published Wednesday in England and Scotland.

But scientists have warned that Omicron is highly contagious and could still lead to more overall severe cases.

France and the United Kingdom on Thursday announced all-time records of COVID-19 daily infections since the start of the pandemic in early 2020.
Countries scrambled to contain surging coronavirus infections driven by the Omicron variant.
People walk in Covent Garden in London, Britain amid the Covid-19 outbreak fuelled by Omicorn. Source: EPA
As families across Europe prepare for Christmas, governments announced a raft of new measures to prevent intensified spread of the new strain, putting a dampener on festivities.

Spain's Catalonia was to reimpose a night-time curfew for a fortnight from Christmas Eve, while Scotland announced it would close nightclubs from next week, including on New Year's Eve.

Europe has been hit hard by the ongoing surge, recording 60 per cent of global cases over the past week,

In other new measures Thursday, Greece said people must wear face masks both indoors and outside during Christmas and New Year's gatherings.

Denmark asked all foreigners, even those vaccinated, to show a negative COVID test to be able to enter the country.

13 million people locked down

Reacting with more stringency, China shut down a city of 13 million people on Thursday in a bid to extinguish a tiny COVID-19 outbreak and chase its zero-case goal.

China locked down the northern city of Xi'an, home to the world-famous Terracotta Warriors, to stamp out a cluster of several hundred cases.
"I think it is necessary to have the lockdown," said a Xi'an resident, who wanted to be identified only as Yuan.

Omicron has not been reported in Xi'an, with only dozens of cases of the less infectious Delta variant detected in the city of 13 million people in recent days.

But the Chinese government, in pursuit of its zero-case strategy ahead of the Beijing Winter Olympics, has ordered all Xi'an residents to stay indoors.

Only one person per household can go outside every two days to buy necessities, while non-essential businesses are closed.

February's Olympics are set to be the most restrictive mass sporting event since the pandemic began, with international spectators banned and all participants required to stay inside a closed-loop system.

COVID pills hope

In business, German national carrier Lufthansa said Omicron forced it to axe 33,000 flights following a drop in bookings.

Denmark discovered an illegal mink farm that had been operating despite a ban, after the country last year culled millions of the animals over fears they could carry coronavirus and jeopardise vaccine effectiveness.

But in some positive news, the US Food and Drug Administration authorised Merck's COVID pill for high-risk adults, a day after giving the green light to a similar Pfizer product.

The pill developed by Merck is taken within five days of symptom onset.
Pfizer's antiviral COVID-19 pill for at-risk people aged 12 and above has been authorised in the US.
Pfizer's antiviral COVID-19 pill for at-risk people aged 12 and above has been authorised in the US. Source: AAP
It has been shown to reduce COVID hospitalisations and deaths by 30 percent among at-risk people, whereas Pfizer's pill reduced the same outcomes by almost 90 percent.

Pills that are available at pharmacies are likely to be much easier to access than synthetic antibody treatments, which require infusions at hospitals or specialised centres.

The United States has spent US$5.3 billion (AUD$7.3 billion) procuring 10 million courses of the Pfizer treatment, according to the White House.

But health authorities maintain that vaccines are still the best protection against any variant, and are encouraging booster shots.

AstraZeneca said Thursday that a third dose of its COVID-19 vaccine "significantly" lifted antibody levels against the Omicron strain in a laboratory study.


Share
4 min read
Published 24 December 2021 7:10am
Updated 22 February 2022 2:04pm
Source: AFP, SBS



Share this with family and friends